Company intelligence / Profile preview

NCK

Farum, Denmark
Ownership
Private
Employees
~25
Development stage
Other
01

Overview

NCK, officially NIELS CLAUSON-KAAS A/S, is a Denmark-based pharmaceutical services company focused on process development, analytical development, and cGMP manufacturing of active pharmaceutical ingredients and advanced intermediates for biotech and pharmaceutical clients. The company operates as a specialized small-molecule chemistry partner supporting programs from discovery through preclinical, clinical, and commercial supply. Its capabilities include synthesis, project management, analytical testing, quality assurance, and operation of a multi-purpose GMP pilot plant. NCK traces its origins to the organic synthesis work of chemist Niels Clauson-Kaas and has built a long-standing reputation in applied chemistry and custom API manufacturing. The business appears to be a niche contract development and manufacturing organization rather than a therapeutics developer with an internal drug pipeline.

Modalities
Small molecule
Industry
Drug Discovery Services
02

Partnerships

Davos PharmaAneeva

Beyond the preview

Go deeper on NCK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NCK.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call